NZX-listed medical cannabis business Cannasouth needs to raise capital in the current quarter to keep the lights on after growing its first-half loss to $3.7 million.
The Waikato business generated income of $1.41m from its Midwest Pharmaceuticals subsidiary in the six months to June 30, compared to
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
